Mansur Arian, Habibollahi Peiman, Fang Adam, Mahvash Armeen, Etezadi Vahid, Liddell Robert P, Camacho Juan C, Cohen Emil I, Kokabi Nima, Arepally Aravind, Georgiades Christos, Nezami Nariman
Harvard Medical School, Boston, MA, USA.
Division of Diagnostic Imaging, Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ther Adv Med Oncol. 2024 Sep 30;16:17588359241280692. doi: 10.1177/17588359241280692. eCollection 2024.
Radioembolization is a locoregional transarterial therapy that combines radionuclide and micron-sized beads to deliver radiation internally to the target tumors based on the arterial blood flow. While initially developed as a palliative treatment option, radioembolization is now used for curative intent treatment, neoadjuvant therapy, and method to downstage or bridge for liver transplant. Radioembolization has become increasingly utilized and is an important therapeutic option for the management of hepatocellular carcinoma and liver metastasis. This article provides an overview of the techniques, challenges, and novel developments in radioembolization, including new dosimetry techniques, radionuclides, and new target tumors.
放射性栓塞是一种局部区域经动脉治疗方法,它将放射性核素与微米级微球相结合,根据动脉血流将辐射内照射到靶肿瘤。虽然放射性栓塞最初是作为一种姑息性治疗选择而开发的,但现在它被用于根治性治疗、新辅助治疗以及用于降低分期或作为肝移植桥梁的方法。放射性栓塞的应用越来越广泛,是肝细胞癌和肝转移瘤治疗的重要选择。本文概述了放射性栓塞的技术、挑战和新进展,包括新的剂量测定技术、放射性核素和新的靶肿瘤。